# East West Bancorp Inc: overview

EWBC · Nasdaq · CIK 1069157 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ewbc.md) · [Financials](/companies/ewbc/financials.md) · [Filings](/companies/ewbc/filings.md) · [Insiders](/companies/ewbc/insiders.md)

Latest reported revenue: [$17.1m](/filings/0001069157-20-000072.md) for Q3 FY2020, three months to 2020-09-30, from the 10-Q filed Nov 6, 2020 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001069157-20-000072).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [2.14](/filings/0001069157-25-000119.md) | not reported | [2.08](/filings/0001069157-26-000020.md) | [2.24](/filings/0001069157-26-000044.md) | [2.65](/filings/0001069157-25-000119.md) | not reported | [2.57](/filings/0001069157-26-000020.md) | [2.63](/filings/0001069157-26-000044.md) |
| Free cash flow | $m | not reported | not reported | [275](/filings/0001069157-26-000020.md) | [277 d](/filings/0001069157-26-000044.md) | not reported | not reported | [330](/filings/0001069157-26-000020.md) | [588 d](/filings/0001069157-26-000044.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [6.10](/filings/0001069157-24-000020.md) | [7.92](/filings/0001069157-25-000025.md) | [8.18](/filings/0001069157-26-000009.md) | [8.33](/filings/0001069157-26-000009.md) | [9.52](/filings/0001069157-26-000009.md) |
| Free cash flow | $m | [1,162](/filings/0001069157-24-000020.md) | not reported | not reported | not reported | not reported |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ewbc/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.74bn | 13,517,378 |  | Added +285,574 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $1.14bn | 8,830,694 |  | Reduced −558,938 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $1.10bn | 8,485,968 |  | Added +801,062 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $851.4m | 6,595,199 |  | Reduced −128,308 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $798.2m | 6,182,969 |  | Added +19,216 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $648.4m | 5,022,525 |  | Added +57,992 |
| [CHARLES SCHWAB INVESTMENT MANAGEMENT INC](/funds/884546.md) | 2026-06-30 | $574.9m | 4,453,454 |  | Added +403,619 |
| [SCHRODER INVESTMENT MANAGEMENT GROUP](/funds/1086619.md) | 2026-06-30 | $514.5m | 3,985,737 |  | Added +120,860 |
| [Boston Partners](/funds/1386060.md) | 2026-06-30 | $461.4m | 3,574,111 |  | Added +130,302 |
| [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $416.6m | 3,227,066 |  | Added +1,484,505 |

## Recent filings

[All 1,131 filings](/companies/ewbc/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-20 | 20:04 ET | [8-K](/filings/0001069157-26-000048.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001069157-26-000048 |
| 2026-08-07 | 20:07 ET | [10-Q](/filings/0001069157-26-000044.md) | Quarterly report, period 2026-06-30 | 0001069157-26-000044 |
| 2026-07-21 | 20:05 ET | [8-K](/filings/0001069157-26-000041.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001069157-26-000041 |
| 2026-05-19 | 20:05 ET | [8-K](/filings/0001069157-26-000022.md) | 5.07 Shareholder vote results | 0001069157-26-000022 |
| 2026-05-08 | 20:07 ET | [10-Q](/filings/0001069157-26-000020.md) | Quarterly report, period 2026-03-31 | 0001069157-26-000020 |
| 2026-04-21 | 20:04 ET | [8-K](/filings/0001069157-26-000016.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001069157-26-000016 |
| 2026-04-08 | 20:00 ET | [DEF 14A](/filings/0002077096-26-000050.md) | Proxy statement, period 2026-05-18 | 0002077096-26-000050 |
| 2026-02-27 | 21:08 ET | [10-K](/filings/0001069157-26-000009.md) | Annual report, period 2025-12-31 | 0001069157-26-000009 |
| 2026-01-22 | 21:07 ET | [8-K](/filings/0001069157-26-000005.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001069157-26-000005 |
| 2025-12-02 | 23:03 ET | [8-K](/filings/0001069157-25-000121.md) | 5.02 Departure or appointment of officers or directors | 0001069157-25-000121 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001069157-26-000009.md), filed Feb 27, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1069157
- Tickers: EWBC
- Exchange: Nasdaq
- SIC code: 6022 State Commercial Banks
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.